Friday, 18 January 2019

Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)